# Multicenter Randomized Controlled Trial to Compare the Outcome of Conservative Triple Target Treatment With EMG-Biofeedback in Chronic Obstipation

> **NCT01672216** · PHASE3 · UNKNOWN · sponsor: **dr. schwandner** · enrollment: 140 (estimated)

## Conditions studied

- Chronic Obstipation

## Interventions

- **DEVICE:** Combination of EMG-biofeedback plus EMG-triggered AM-MF-stimulation
- **DEVICE:** EMG-biofeedback alone

## Key facts

- **NCT ID:** NCT01672216
- **Lead sponsor:** dr. schwandner
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-08
- **Primary completion:** 2014-05
- **Final completion:** 2015-05
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2013-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01672216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01672216, "Multicenter Randomized Controlled Trial to Compare the Outcome of Conservative Triple Target Treatment With EMG-Biofeedback in Chronic Obstipation". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01672216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*